TD Asset Management
MRTX

TD Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

TD Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-213,218
Closed -$9.29M – 1470
2023
Q3 		$9.29M Buy
213,218
+141,113
+196% +$6.15M 0.01% 600
2023
Q2 		$2.61M Buy
72,105
+4,700
+7% +$170K ﹤0.01% 898
2023
Q1 		$2.51M Buy
67,405
+13,300
+25% +$494K ﹤0.01% 914
2022
Q4 		$2.45M Buy
54,105
+22,970
+74% +$1.04M ﹤0.01% 928
2022
Q3 		$2.18M Hold
31,135
– – ﹤0.01% 975
2022
Q2 		$2.09M Sell
31,135
-16,100
-34% -$1.08M ﹤0.01% 996
2022
Q1 		$3.88M Sell
47,235
-15,796
-25% -$1.3M ﹤0.01% 883
2021
Q4 		$9.25M Buy
63,031
+1,700
+3% +$249K 0.01% 699
2021
Q3 		$10.9M Buy
61,331
+4,091
+7% +$724K 0.01% 633
2021
Q2 		$9.16M Buy
57,240
+20,186
+54% +$3.23M 0.01% 671
2021
Q1 		$6.35M Buy
37,054
+1,710
+5% +$293K 0.01% 762
2020
Q4 		$7.76M Buy
35,344
+9,154
+35% +$2.01M 0.01% 669
2020
Q3 		$4.35M Buy
26,190
+1,000
+4% +$166K 0.01% 741
2020
Q2 		$2.88M Buy
25,190
+2,500
+11% +$285K ﹤0.01% 794
2020
Q1 		$1.74M Sell
22,690
-5,787
-20% -$445K ﹤0.01% 861
2019
Q4 		$3.67M Sell
28,477
-1,700
-6% -$219K 0.01% 787
2019
Q3 		$2.35M Buy
30,177
+2,777
+10% +$216K ﹤0.01% 876
2019
Q2 		$2.82M Buy
27,400
+7,800
+40% +$803K ﹤0.01% 836
2019
Q1 		$1.44M Buy
19,600
+3,800
+24% +$279K ﹤0.01% 976
2018
Q4 		$670K Buy
15,800
+300
+2% +$12.7K ﹤0.01% 1158
2018
Q3 		$730K Buy
15,500
+7,300
+89% +$344K ﹤0.01% 1223
2018
Q2 		$404K Buy
8,200
+200
+3% +$9.85K ﹤0.01% 1306
2018
Q1 		$246K Buy
+8,000
New +$246K ﹤0.01% 1298